on 14 Jul 2020
Last Applicant/ Owned by
CH-4057 Basel
CH
Serial Number
79246636 filed on 01st Nov 2018
Registration Number
6098248 registered on 14th Jul 2020
Correspondent Address
Anthony E. Bennett
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical and veterinary products, for the treatment of cancer and for regenerative medicine; pharmaceutical preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; pharmaceutical products, namely small molecule drugs for the treatment of cancer; pharmaceutRead More
Chemical products for use in industry and science, namely, chemicals for use in the manufacture of pharmaceutical and veterinary products; Chemicals for use in biotechnological product development
Pharmaceutical and veterinary products, for the treatment of cancer and for regenerative medicine; pharmaceutical preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; pharmaceutical products, namely small molecule drugs for the treatment of cancer; pharmaceutical products for the treatment of NOTCH-dependent cancers; medicinal preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; veterinary medicines for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; chemical and pharmaceutical preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; diagnostic preparations for medical use; chemical and pharmaceutical preparations for veterinary use for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders
Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals; research, development of products and quality control in the field of pharmacy; research in the field of chemistry and biology; industrial analysis and research services in the field of pharmaceuticals; research and development of pharmaceutical and veterinary products; chemical analysis and research in the field of pharmaceuticals
No 79246636
No Service Mark
No 226827IntlUS
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 21st Nov 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 03rd Nov 2020 | FINAL DISPOSITION PROCESSED |
| 03rd Nov 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| 14th Oct 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 14th Jul 2020 | REGISTERED-PRINCIPAL REGISTER |
| 04th Jun 2020 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 15th May 2020 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 29th Apr 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 29th Apr 2020 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 26th Mar 2020 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
